View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| NRC | RIN: 3150-AI26 | Publication ID: Fall 2010 |
| Title: Medical Use of Byproduct Material--Amendments/Medical Event Definition [NRC-2008-0071] | |
| Abstract: The proposed rule would amend the Commission's regulations that govern medical use of byproduct material related to reporting and notifications of medical events to clarify requirements for permanent implant branchytherapy. | |
| Agency: Nuclear Regulatory Commission(NRC) | Priority: Substantive, Nonsignificant |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Long-Term Actions |
| Major: No | Unfunded Mandates: No |
| CFR Citation: 10 CFR 35 | |
| Legal Authority: 42 USC 2201 42 USC 5841 | |
|
Legal Deadline:
None |
||||||||||||||||||||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
| Small Entities Affected: No | |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Edward M. Lohr Nuclear Regulatory Commission Office of Nuclear Material Safety and Safeguards, Washington, DC 20555-0001 Phone:301 415-0253 Email: edward.lohr@nrc.gov |
|
An official website of the United States government



